Stockscreener 앱 받기
0.574
2.48%
0.014
전일 마감가:
$0.56
열려 있는:
$0.56
하루 거래량:
2.02M
Relative Volume:
0.73
시가총액:
$81.97M
수익:
$15.93M
순이익/손실:
$-64.59M
주가수익비율:
-0.7653
EPS:
-0.75
순현금흐름:
$-59.50M
1주 성능:
-6.10%
1개월 성능:
-22.18%
6개월 성능:
-30.76%
1년 성능:
+17.12%
1일 변동 폭
$0.539
$0.5841
1주일 범위
$0.534
$0.62
52주 변동 폭
$0.3612
$1.92
Veru Inc Stock (VERU) Company Profile
명칭
Veru Inc
전화
(312) 595-9123
주소
2916 N. MIAMI AVENUE, MIAMI, FL
VERU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
0.5739 | 81.97M | 15.93M | -64.59M | -59.50M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.91 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
713.82 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
668.82 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.97 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.44 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-14 | 개시 | B. Riley Securities | Buy |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2023-06-07 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-02-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-01-21 | 재확인 | H.C. Wainwright | Buy |
| 2019-03-20 | 개시 | Oppenheimer | Outperform |
| 2018-07-03 | 개시 | Maxim Group | Buy |
모두보기
Veru Inc 주식(VERU)의 최신 뉴스
Veru Inc (VERU) Shares Down Despite Recent Market Volatility - The News Heater
Veru Inc (VERU Stock: A Sea of Opportunity - The InvestChronicle
Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire
Veru (VERU) Projected to Post Earnings on Thursday - MarketBeat
Veru Inc (VERU) is looking forward to a strong quarter - SETE News
What will the future hold for Veru Inc (NASDAQ:VERU) stock? - US Post News
Veru (VERU) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Oppenheimer maintains Veru stock Outperform rating, $5 target - MSN
Veru (VERU) to Release Quarterly Earnings on Thursday - Defense World
Veru shares plunge despite positive data in obesity trial - pharmaphorum
Oppenheimer maintains Veru stock Outperform rating, $5 target By Investing.com - Investing.com Australia
Veru Hopes To Improve The QUALITY Of Drug-Induced Weight Loss - Citeline
S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher - Benzinga
Veru’s Drug Spares Lean Mass in Overweight, Obese Adults on Wegovy—Is It Enough? - BioSpace
Muscle-building drug improves body composition in obesity trial, Veru says - BioPharma Dive
Dow Edges Higher; AT&T Posts Upbeat Earnings - Benzinga
Veru's experimental drug helps older obese patients on Wegovy preserve muscle - Reuters
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough - Benzinga
Nasdaq Dips 3%; Chicago Fed National Activity Index Rises In December - Benzinga
Veru down 46% despite data for drug preserving lean body mass in Wegovy users - Seeking Alpha
Veru Reports Positive Data From Phase 2b QUALITY Study - Nasdaq
Veru’s enobosarm meets primary endpoint in Phase 2b weight reduction trial - TipRanks
Veru says its drug preserved lean mass in patients taking Wegovy - STAT
Veru Announces Positive Topline Data from Phase 2b QUALITY - GlobeNewswire
Veru's Enobosarm + Wegovy Trial Shows 71% Better Muscle Preservation in Weight Loss Study - StockTitan
Oppenheimer maintains Veru stock Outperform rating as trial nears - MSN
What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now? - MSN
Novo weight-loss data roll out; Veru ‘leans’ in - BioWorld Online
Oppenheimer maintains Veru stock Outperform rating as trial nears By Investing.com - Investing.com Canada
Items Tagged with 'enobosarm' - BioWorld Online
Investors Purchase High Volume of Veru Call Options (NASDAQ:VERU) - Defense World
Veru Target of Unusually High Options Trading (NASDAQ:VERU) - MarketBeat
Investors Buy Large Volume of Veru Call Options (NASDAQ:VERU) - MarketBeat
Jane Street Group LLC Has $74,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
3 US Penny Stocks With Market Caps Under $200M To Consider - Simply Wall St
Will QUALITY Add More Weight To Veru Stock? - RTTNews
What is B. Riley's Forecast for Veru Q1 Earnings? - MarketBeat
What is B. Riley’s Forecast for Veru Q1 Earnings? - Defense World
Veru Inc. (NASDAQ:VERU) Shares Purchased by Geode Capital Management LLC - Defense World
Barclays PLC Has $142,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
H.C. Wainwright maintains target on Veru stock post-sale By Investing.com - Investing.com Nigeria
Veru Inc. Sells FC2 Business to Focus on Biopharma - TipRanks
Veru (NASDAQ:VERU) Receives “Buy” Rating from HC Wainwright - Defense World
H.C. Wainwright maintains target on Veru stock post-sale - Investing.com India
Miami Biopharma Sells Part of Business & Begins New Clinical Trial - Streetwise Reports
Veru's (VERU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Veru Inc. (NASDAQ:VERU) Shares Bought by State Street Corp - Defense World
Biopharma company to cut 90% of jobs after sale - The Business Journals
Veru Inc (VERU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
3.35%
자본화:
|
볼륨(24시간):